TuHURA Biosciences, Inc./NV 8-K

What Happened

• TuHURA Biosciences, Inc. announced it entered into a Loan Agreement with Parkview Holdings One LLC (the lender) on April 21, 2026, establishing a revolving credit facility with up to $50 million in availability that matures April 21, 2031.
• On May 26, 2026, TuHURA took its first draw under the facility for $1,700,000 and said the funds are expected to be used for general corporate purposes. The full Loan Agreement was previously filed as an exhibit to an 8-K on April 22, 2026.

Key Details

• Lender: Parkview Holdings One LLC (an affiliate of the company’s largest stockholder is referenced as a potential conflict).
• Facility size: Up to $50,000,000 in revolving availability.
• First draw: $1,700,000 received on May 26, 2026.
• Maturity date: April 21, 2031.
• Filing: Description of the Loan Agreement was previously filed as Exhibit 4.1 to the Company’s April 22, 2026 Form 8-K.

Why It Matters

• The draw provides immediate liquidity ($1.7M) and gives TuHURA access to a larger committed funding source (up to $50M) that could help fund operations and development programs without immediate equity issuance.
• Availability is subject to the Loan Agreement’s terms and conditions; the company cautions that it may face risks drawing additional funds, complying with the credit terms, or potential conflicts of interest tied to the lender. Investors should monitor future disclosures about additional draws, covenant compliance, and capital needs.